T1	Entity 26 32	5q11.2
T2	Cancer 33 46	breast cancer
T3	Association 88 92	risk
E1	Association:T3 bc:T2 snp_int:T4
T4	SNP 70 87;93 101	three independent variants
R1	SNP_location Arg1:T4 Arg2:T1	
T5	Gene_Regulation 102 112	regulating
E2	Gene_Regulation:T5 Theme:T6 Agent:T4
T6	Entity 113 119	MAP3K1
T7	SNP 179 187	rs889312
T8	Entity 191 197	5q11.2
R2	SNP_location Arg1:T7 Arg2:T8	
T9	Association 204 214	associated
E3	Association:T9 bc:T10 snp_int:T7
T10	Cancer 220 233	breast cancer
T11	Entity 242 268	women of European ancestry
R3	Population_assignment Arg1:T7 Arg2:T11	
T12	Entity 662 674	minor allele
T13	SNP 698 708	rs62355902
R4	SNP_allele Arg1:T13 Arg2:T12	
T14	Association 710 720	associated
E4	Association:T14 snp_int:T13 bc:T18 bc2:T17
T15	Level 726 739	significantly
T16	Effect_Type 740 749	increased
A1	Effect_Type E4 Increase
A2	Level E4 High
R5	Level_marker Arg1:E4 Arg2:T15	
R6	Effect_type_marker Arg1:E4 Arg2:T16	
T17	Cancer 764 790;982 988	estrogen-receptor-positive tumors
A3	Cancer_Type T17 ER+
T18	Cancer 893 919;982 988	estrogen-receptor-negative tumors
A4	Cancer_Type T18 ER-
T19	Entity 764 781	estrogen-receptor
T20	Entity 792 794	ER
R7	Equiv Arg1:T20 Arg2:T19	
T21	Effect_Type 782 790	positive
T22	Entity 893 910	estrogen-receptor
T23	Entity 921 923	ER
R8	Equiv Arg1:T22 Arg2:T23	
T24	Neg 911 919	negative
T25	Organic_inorganic_molecules_affected 710 720	associated
E5	Organic_inorganic_molecules_affected:T25 Agent:T13 Theme:T23
E6	Organic_inorganic_molecules_affected:T25 Agent:T13 Theme:T19
A5	Effect_Type E6 Increase
R9	Effect_type_marker Arg1:E6 Arg2:T21	
R10	Negation_marker Arg1:E5 Arg2:T24	
T26	SNP 1011 1021	rs62355902
T28	Interaction 622 632	correlated
E7	Interaction:T28 Entity:T29
T29	SNP 619 621;633 641	15 variants
T30	Entity 643 649	iCHAV1
T31	Level 586 595	strongest
T32	Association 596 608	associations
E8	Association:T32 snp_int:E7 bc:T10
R13	Level_marker Arg1:E8 Arg2:T31	
A6	Level E8 High
T33	Spec 1032 1040	evidence
T34	Association 1044 1055	association
E9	Association:T34 bc:T10 snp_int:E14 snp_int2:E13
R14	Speculation_marker Arg1:E9 Arg2:T33	
T35	SNP 1069 1081	173 variants
T36	Entity 1083 1089	iCHAV2
T37	SNP 1159 1170	rs113317823
T38	Level 1145 1154	strongest
T39	Association 1132 1139	effects
E10	Association:T39 snp_int:T37 bc:T10
A7	Level E10 High
T40	Entity 372 378	5q11.2
T41	Entity 1224 1230	iCHAV3
T42	SNP 1237 1247	rs11949391
T43	Level 1232 1236	lead
T44	Entity 1249 1251	ER
T45	Effect_Type 1252 1253	+
T46	Cancer 1249 1254	ER(+)
A8	Cancer_Type T46 ER+
E11	Association:T39 bc:T46 snp_int:T42
R20	Level_marker Arg1:E10 Arg2:T38	
A9	Level E11 High
R23	Level_marker Arg1:E11 Arg2:T43	
T49	Organic_inorganic_molecules_affected 1132 1139	effects
E12	Organic_inorganic_molecules_affected:T49 Agent:T42 Theme:T44
R24	Effect_type_marker Arg1:E12 Arg2:T45	
A10	Effect_Type E12 Increase
T50	SNP 1200 1213	five variants
T51	Entity 1564 1576	risk alleles
T52	SNP 1597 1607	rs74345699
T53	SNP 1612 1622	rs62355900
T54	SNP 1633 1643	rs16886397
T55	SNP 1659 1669	rs17432750
T56	Interaction 1214 1223	composing
E13	Interaction:T56 Entity:T50
T57	Interaction 1083 1089	iCHAV2
E14	Interaction:T57 Entity:T35
R26	SNP_allele Arg1:T52 Arg2:T51	
R27	SNP_allele Arg1:T53 Arg2:T51	
T59	Entity 1624 1630	iCHAV1
T61	Entity 1645 1652	iCHAV2a
T63	Entity 1671 1677	iCHAV3
R31	SNP_allele Arg1:T54 Arg2:T51	
R32	SNP_allele Arg1:T55 Arg2:T51	
T64	Effect_Type 1680 1689	increased
T65	Entity 1690 1696	MAP3K1
T66	Spec 1538 1547	indicated
T67	Gene_Regulation 1697 1721	transcriptional activity
E18	Gene_Regulation:T67 Theme:T65 Agent:T55 Agent2:T54 Agent3:T53 Agent4:T52
A11	Effect_Type E18 Increase
R33	Effect_type_marker Arg1:E18 Arg2:T64	
R34	Speculation_marker Arg1:E18 Arg2:T66	
T68	Effect_Type 1771 1781	diminished
T69	Gene_Regulation 1788 1795	binding
E19	Gene_Regulation:T69 Theme:T70 Agent:T72
T70	Entity 1782 1787	GATA3
R35	Effect_type_marker Arg1:E19 Arg2:T68	
A12	Effect_Type E19 Decrease
T71	Entity 1803 1808;1829 1835	minor allele
T72	SNP 1839 1849	rs17432750
R36	SNP_allele Arg1:T72 Arg2:T71	
T73	Entity 1810 1827	cancer-protective
R37	Equiv Arg1:T71 Arg2:T73	
T74	Spec 1893 1900	propose
T75	Entity 1917 1929	risk alleles
T76	SNP 1910 1929	cancer risk alleles
R38	SNP_allele Arg1:T76 Arg2:T75	
T77	Effect_Type 1937 1945	increase
T78	Gene_Regulation 1953 1971	expression inÂ vivo
E20	Gene_Regulation:T78 Theme:T79 Agent:T76
T79	Entity 1946 1952	MAP3K1
R39	Effect_type_marker Arg1:E20 Arg2:T77	
R40	Speculation_marker Arg1:E20 Arg2:T74	
T80	Spec 1976 1981	might
T81	Cell_types_tissues_affected 2004 2017	cell survival
E21	Cell_types_tissues_affected:T81 Theme:T83 Agent:T76
T82	Effect_Type 1982 1989	promote
T83	Entity 1990 2008	breast cancer cell
R41	Effect_type_marker Arg1:E21 Arg2:T82	
A13	Effect_Type E21 Increase
A14	Effect_Type E20 Increase
R42	Speculation_marker Arg1:E21 Arg2:T80	
R18	SNP_location Arg1:T42 Arg2:T40	
A15	SNP_Class T42 Index_lead_SNP
A16	SNP_Class T37 Index_lead_SNP
T84	SNP 550 580	three independent risk signals
R47	Equiv Arg1:T84 Arg2:T4	
R48	SNP_location Arg1:E7 Arg2:T30	
R49	Member Arg1:T29 Arg2:T13	
A17	SNP_Class T13 Index_lead_SNP
R11	SNP_location Arg1:E14 Arg2:T36	
R12	Member Arg1:T35 Arg2:T37	
R15	Member Arg1:T40 Arg2:T30	
R16	Member Arg1:T40 Arg2:T36	
R17	SNP_location Arg1:E13 Arg2:T41	
R21	Member Arg1:T50 Arg2:T42	
R22	Member Arg1:T8 Arg2:T41	
R25	SNP_location Arg1:T53 Arg2:T59	
R28	SNP_location Arg1:T54 Arg2:T61	
R29	SNP_location Arg1:T55 Arg2:T63	
R30	SNP_location Arg1:T52 Arg2:T59	
R19	Equiv Arg1:T41 Arg2:T63	
R43	Equiv Arg1:T59 Arg2:T30	
R44	Member Arg1:T8 Arg2:T61	
R45	Member Arg1:T84 Arg2:E7	
R46	Member Arg1:T84 Arg2:E14	
R50	Member Arg1:T84 Arg2:E13	
